Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:06 PM
Ignite Modification Date:
2025-12-24 @ 7:06 PM
NCT ID:
NCT06191757
Eligibility Criteria:
Inclusion Criteria:Criteria for including babies in the study;
* Premature babies born as singletons at 27-0/7 - 36-6/7 weeks of gestation,
* Premature babies whose corrected age was at the 40th week of gestation (to start the developmental support program)
* Mothers could speak, read and write Turkish were included in the study.
Exclusion Criteria:The exclusion criteria for babies from the study are as follows:
* Those diagnosed with perinatal or neonatal asphyxia, those with congenital anomalies, those with Stage 3-4 intracranial or intraventricular hemorrhage,
* Those who were given sedative opioids and anticonvulsant drugs
* Whose mothers had disabilities in communication (vision, hearing, speech)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
3 Months
Study:
NCT06191757
Study Brief:
Protocol Section:
NCT06191757